APA (7th ed.) Citation

Li, J., Chen, R., Wang, X., Zheng, Q., & Dai, R. (2025). Conserved sphingolipid metabolism under transcriptomic diversity: A prognostic and therapeutic target in triple-negative breast cancer. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-07264-x

Chicago Style (17th ed.) Citation

Li, Jian, Rui Chen, Xiaowu Wang, Qing Zheng, and Ruijie Dai. "Conserved Sphingolipid Metabolism Under Transcriptomic Diversity: A Prognostic and Therapeutic Target in Triple-negative Breast Cancer." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-07264-x.

MLA (9th ed.) Citation

Li, Jian, et al. "Conserved Sphingolipid Metabolism Under Transcriptomic Diversity: A Prognostic and Therapeutic Target in Triple-negative Breast Cancer." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-07264-x.